Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea

Bone Marrow Transplant. 1994:14 Suppl 3:S34-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Separation*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematopoiesis
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Hydroxyurea / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Philadelphia Chromosome*

Substances

  • Granulocyte Colony-Stimulating Factor
  • Hydroxyurea